These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. First genome-wide study of infectious disease opens new avenues for HIV treatment: vaccines. AIDS Patient Care STDS; 2007 Aug; 21(8):607. PubMed ID: 17902246 [No Abstract] [Full Text] [Related]
4. Keystone HIV pathogenesis and vaccine development report. Hardy G GMHC Treat Issues; 2004; 18(5-6):6-8. PubMed ID: 15359437 [No Abstract] [Full Text] [Related]
5. Vaccines. From Brazil and France: a vaccine against HIV may lower viral load. TreatmentUpdate; 2005; 17(1):10-1. PubMed ID: 17228459 [No Abstract] [Full Text] [Related]
6. AIDS vaccine development and challenge viruses: getting real. Vlasak J; Ruprecht RM AIDS; 2006 Nov; 20(17):2135-40. PubMed ID: 17086052 [No Abstract] [Full Text] [Related]
12. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
13. Murine models for HIV vaccination and challenge. Boberg A; BrĂ¥ve A; Johansson S; Wahren B; Hinkula J; Rollman E Expert Rev Vaccines; 2008 Feb; 7(1):117-30. PubMed ID: 18251698 [TBL] [Abstract][Full Text] [Related]
14. AIDS vaccine blueprint launched: a challenge to the field. McEnery R IAVI Rep; 2008; 12(4):15. PubMed ID: 20213990 [No Abstract] [Full Text] [Related]
15. Use of predictive markers of HIV disease progression in vaccine trials. Gurunathan S; Habib RE; Baglyos L; Meric C; Plotkin S; Dodet B; Corey L; Tartaglia J Vaccine; 2009 Mar; 27(14):1997-2015. PubMed ID: 19200450 [TBL] [Abstract][Full Text] [Related]
16. First AIDS vaccine trial launched. Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708 [No Abstract] [Full Text] [Related]
17. AIDS clinical research for New Yorkers. GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300 [No Abstract] [Full Text] [Related]
18. HIV transmission: the genetic bottleneck. Newspaper Article. Noble S IAVI Rep; 2008; 12(6):4-8. PubMed ID: 20218017 [No Abstract] [Full Text] [Related]
19. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630 [TBL] [Abstract][Full Text] [Related]
20. Encouraging vaccine results from primate models of HIV type 1 infection. Schultz A AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S261-3. PubMed ID: 9814953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]